Immune-Frame

Immune-Frame provides a detailed and thorough analysis of the condition and status of a patient’s immune system. Scientists study a patient’s blood sample to detect cytokines produced by specific cells and to identify blood-borne markers. The test uses specific advanced tissue analysis techniques to detect the type or types of cells that are responsible for switching a patient’s immune system on and off. 

The results provide a personalised analysis of the strength of the immune system and can highlight potential risks a patient faces. Clinicians can use the information and guidance for patients.

Immune-Frame uses two different tests, or assays, to establish the current condition of the immune system. The ELISA assay is used to detect cytokines produced by specific cells. Flow cytometry is used to measure specific markers on blood cells in the peripheral vascular system. 

Scientists compare these assays to a control sample to identify any variation. The results are provided according to the format in the following table.

Research has established that the methods used in Immune-Frame are highly accurate and effective.

Immune-Frame test requires 15-25 ml of whole (peripheral) blood, to be sent in a liquid preservative in a 50ml volume Falcon tube.

At RGCC, we provide ongoing training and support for clinicians on how to conduct tests and interpret the results for patients. If you would like more information on how to access, perform or analyse the results of Immune-Frame, then get in touch today.